封面
市场调查报告书
商品编码
1858792

兽用调味药品:全球市场份额和排名、总销售额和需求预测(2025-2031 年)

Flavored Veterinary Medication - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

出版日期: | 出版商: QYResearch | 英文 119 Pages | 商品交期: 2-3个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2024 年全球兽用调味药品市场规模估计为 35.73 亿美元,预计到 2031 年将达到 66.01 亿美元,在 2025 年至 2031 年的预测期内,复合年增长率为 9.3%。

调味动物医药是指添加了特定香料、遮罩味剂或改良剂型的兽药。这些产品旨在透过提高动物的自愿摄取量和治疗依从性来改善临床疗效和用药体验。这些产品主要针对伴侣动物(例如犬、猫和鸟类)以及部分家畜,包括处方笺和非处方药的调味口服片剂、咀嚼片、液体、混悬液和饲料混合製剂。调味旨在克服动物的天然厌恶(例如苦味、难闻的气味、难闻的口感),同时优化特定物种的偏好(例如对肉类或鱼类的偏好)和质地,从而简化给药、减轻压力反应并提高疗程完成率。除了调味之外,现代调味动物医药还强调与给药系统的协同作用以及给药的便利性(例如咀嚼片、口服糊剂和预混合料饲料)。他们还必须遵守严格的安全、残留和兽医监管标准,以保护动物和人类食物链的安全。

宠物饲养率的上升、宠物拟人化趋势的增强以及宠物医疗保健成本的不断攀升,推动了兽用调味药品的需求增长,将其视为提高遵守用药、减轻动物应激反应和提高治疗完成率的实用解决方案。根据年度报告显示,大型兽药公司正透过产品系列拓展、併购和地理扩张,将偏好和製剂技术融入其核心策略。监管机构对可接受的剂型和偏好声明的明确规定,也使合规途径更加清晰。调味技术(微囊化、缓释性)的进步提高了调味料的持久性和安全性,使产品适用于慢性治疗和长期给药,从而推动了偏好创新,使其成为成长的核心驱动力。

关键阻碍因素包括监管机构对已批准的香料化合物、添加剂残留及其对人类食品安全的影响的严格审查,这迫使企业在创新与年度报告中披露的合规成本之间寻求平衡。香料和添加剂之间的相互作用会影响药物的稳定性和生物利用度,因此需要进行高成本的相容性和毒性测试。处方药和复方製剂监管的模糊性以及对复方製剂监管力度的加大,都可能对小型药房和兽药复方製剂模式造成衝击。最后,老牌兽药巨头和特种香料供应商的竞争也会挤压小型公司的利润空间。

下游市场需求正从纯粹的功能性和偏好转向情境化和服务导向型需求。宠物饲主和兽医都在寻求便捷的给药方式、减轻压力以及与居家照护的兼容性。这推动了对便捷剂型(单次使用的口服贴片、咀嚼片、即用型液体)、多样化口味以及针对不同年龄、品种和偏好定制的解决方案的需求。食品安全和公共卫生的考量也要求畜牧业需要安全、相容的调味解决方案,以平衡偏好和残留控制。临床指南和公司年度报告中的策略性倡议表明,市场对标准化、可规模化生产的调味兽药的需求日益增长。

上游工程关键原料包括天然或合成香料化合物、甜味剂、遮罩味剂、质地改良辅料和粘合剂,以及与活性药物成分相容的载体和稳定剂。挑战在于确保香料原料和活性成分的理化相容性、稳定性和毒理学安全性。由于原材料的差异性、供应商集中度以及进出口法规(尤其是天然萃取物),供应也存在风险。永续性和负责任的采购同样重要。天然香料成分易受气候变迁的影响,而合成替代品必须符合安全性和可接受性标准。大型兽药公司在年度报告中强调了供应商选择标准、原材料可追溯性和符合GMP规范的辅料采购的重要性,这些因素同时也增加了成本和市场进入门槛。该产品的毛利率约为55%。

本报告旨在按地区/国家、类型和应用对全球兽用调味药品市场进行全面分析,重点关注总收入、市场份额和主要企业的排名。

本报告以销售收入为指标,对兽用调味药品市场规模、估算和预测进行了呈现,以2024年为基准年,并涵盖了2020年至2031年的历史数据和预测数据。定量和定性分析将帮助读者制定兽用调味药品业务/成长策略,评估市场竞争,分析自身在当前市场中的地位,并做出明智的商业决策。

市场区隔

公司

  • Boehringer Ingelheim
  • Elanco Animal Health
  • Zoetis
  • Merck & Co.
  • Ceva
  • Vetoquinol
  • Wedgewood Pharmacy
  • Virbac
  • BOVA
  • Lee Silsby Compounding Pharmacy
  • Golden Gate
  • China Animal Healthcare
  • Qingdao Yibang
  • Rupu Bio

按类型分類的细分市场

  • 肉味
  • 鱼味
  • 水果味
  • 其他的

应用领域

  • 其他的

按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太地区
    • 中国
    • 日本
    • 韩国
    • 东南亚
    • 印度
    • 澳洲
    • 亚太其他地区
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 荷兰
    • 北欧国家
    • 其他欧洲
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 其他拉丁美洲
  • 中东和非洲
    • 土耳其
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 其他中东和非洲地区

The global market for Flavored Veterinary Medication was estimated to be worth US$ 3573 million in 2024 and is forecast to a readjusted size of US$ 6601 million by 2031 with a CAGR of 9.3% during the forecast period 2025-2031.

Flavored veterinary medication refers to animal medicinal products formulated with specific flavoring agents, taste-masking excipients, or modified dosage forms designed to enhance voluntary intake and treatment adherence, thereby improving clinical outcomes and the medication experience. These products span companion animals (dogs, cats, birds, etc.) and some confined livestock, and include flavored oral tablets, chewables, liquids, suspensions, and feed-mix formulations, both prescription and OTC. Flavoring aims to overcome animals' innate aversions-bitterness, off-odors or unpleasant textures-by using species-targeted flavors (e.g., meat, fish preferences) and textural optimization to simplify administration, reduce stress, and increase completion rates of therapeutic courses. Beyond flavor addition, modern flavored veterinary medicines emphasize synergy with delivery systems and dosage convenience (chewables, oral pastes, premixed feed), and must comply with strict safety, residue and veterinary regulatory standards to protect both animal and human food-chain safety.

Rising pet ownership, pet humanization, and upgraded pet healthcare spending drive demand for flavored veterinary medications as practical solutions to improve adherence, reduce animal stress, and improve therapeutic completion. Corporate annual reports indicate that major animal-health companies are integrating palatability and formulation capabilities into core strategies through product portfolio expansion, M&A and geographic growth; regulatory clarifications on acceptable dosage forms and palatability claims provide clearer compliance pathways. Advances in flavor technology (microencapsulation, controlled release) allow flavor longevity and safety, enabling products suitable for chronic therapies and long-term dosing-making palatability innovation a central growth driver.

Key constraints include regulatory scrutiny over permitted flavoring compounds, excipient residues and impacts on human food safety, requiring companies to balance innovation with compliance costs disclosed in annual reports. Flavor-excipient interactions can affect drug stability and bioavailability, necessitating costly compatibility and toxicology studies. Regulatory ambiguity between prescription and compounded products, and tighter oversight on compounding, can disrupt small compounding pharmacies and veterinary compounding models. Finally, competition from established animal-health majors and specialized flavor suppliers can compress margins for smaller players.

On the downstream side, demand is shifting from purely functional palatability to context-driven and service-oriented needs: pet owners and veterinarians want convenient administration, stress reduction, and home-care suitability. This drives demand for convenient dosage forms (single-use oral strips, chewables, ready-to-use liquids), diversified flavor portfolios, and tailored solutions for age, breed and preference. Food-safety and public-health considerations also propel the livestock sector to seek safe, mixable flavoring solutions that balance palatability with residue control. Clinical guidelines and strategic commitments in corporate annual reports point to increasing demand for standardized, scalable flavored veterinary products.

Key upstream inputs include natural or synthetic flavor compounds, sweeteners and taste-masking agents, textural excipients and binders, as well as carriers and stabilizers compatible with active pharmaceutical ingredients. Challenges include ensuring physicochemical compatibility, stability and toxicological safety of flavor materials with actives; supply risks arise from raw-material variability, supplier concentration and import/export controls (notably for natural extracts). Sustainability and responsible sourcing matter-natural flavor feedstocks can be climate-sensitive, while synthetic alternatives must meet safety and acceptance thresholds. Leading animal-health companies highlight in annual reports the critical importance of supplier qualification, raw-material traceability and GMP-grade excipient sourcing-factors that elevate both cost and market entry barriers.The gross profit margin of this product is around 55%.

This report aims to provide a comprehensive presentation of the global market for Flavored Veterinary Medication, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Flavored Veterinary Medication by region & country, by Type, and by Application.

The Flavored Veterinary Medication market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Flavored Veterinary Medication.

Market Segmentation

By Company

  • Boehringer Ingelheim
  • Elanco Animal Health
  • Zoetis
  • Merck & Co.
  • Ceva
  • Vetoquinol
  • Wedgewood Pharmacy
  • Virbac
  • BOVA
  • Lee Silsby Compounding Pharmacy
  • Golden Gate
  • China Animal Healthcare
  • Qingdao Yibang
  • Rupu Bio

Segment by Type

  • Meat Flavored
  • Fish Flavored
  • Fruit Flavored
  • Others

Segment by Application

  • Dogs
  • Cats
  • Other

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Flavored Veterinary Medication company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Revenue of Flavored Veterinary Medication in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Revenue of Flavored Veterinary Medication in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

  • 1.1 Flavored Veterinary Medication Product Introduction
  • 1.2 Global Flavored Veterinary Medication Market Size Forecast (2020-2031)
  • 1.3 Flavored Veterinary Medication Market Trends & Drivers
    • 1.3.1 Flavored Veterinary Medication Industry Trends
    • 1.3.2 Flavored Veterinary Medication Market Drivers & Opportunity
    • 1.3.3 Flavored Veterinary Medication Market Challenges
    • 1.3.4 Flavored Veterinary Medication Market Restraints
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global Flavored Veterinary Medication Players Revenue Ranking (2024)
  • 2.2 Global Flavored Veterinary Medication Revenue by Company (2020-2025)
  • 2.3 Key Companies Flavored Veterinary Medication Manufacturing Base Distribution and Headquarters
  • 2.4 Key Companies Flavored Veterinary Medication Product Offered
  • 2.5 Key Companies Time to Begin Mass Production of Flavored Veterinary Medication
  • 2.6 Flavored Veterinary Medication Market Competitive Analysis
    • 2.6.1 Flavored Veterinary Medication Market Concentration Rate (2020-2025)
    • 2.6.2 Global 5 and 10 Largest Companies by Flavored Veterinary Medication Revenue in 2024
    • 2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Flavored Veterinary Medication as of 2024)
  • 2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

  • 3.1 Introduction by Type
    • 3.1.1 Meat Flavored
    • 3.1.2 Fish Flavored
    • 3.1.3 Fruit Flavored
    • 3.1.4 Others
  • 3.2 Global Flavored Veterinary Medication Sales Value by Type
    • 3.2.1 Global Flavored Veterinary Medication Sales Value by Type (2020 VS 2024 VS 2031)
    • 3.2.2 Global Flavored Veterinary Medication Sales Value, by Type (2020-2031)
    • 3.2.3 Global Flavored Veterinary Medication Sales Value, by Type (%) (2020-2031)

4 Segmentation by Application

  • 4.1 Introduction by Application
    • 4.1.1 Dogs
    • 4.1.2 Cats
    • 4.1.3 Other
  • 4.2 Global Flavored Veterinary Medication Sales Value by Application
    • 4.2.1 Global Flavored Veterinary Medication Sales Value by Application (2020 VS 2024 VS 2031)
    • 4.2.2 Global Flavored Veterinary Medication Sales Value, by Application (2020-2031)
    • 4.2.3 Global Flavored Veterinary Medication Sales Value, by Application (%) (2020-2031)

5 Segmentation by Region

  • 5.1 Global Flavored Veterinary Medication Sales Value by Region
    • 5.1.1 Global Flavored Veterinary Medication Sales Value by Region: 2020 VS 2024 VS 2031
    • 5.1.2 Global Flavored Veterinary Medication Sales Value by Region (2020-2025)
    • 5.1.3 Global Flavored Veterinary Medication Sales Value by Region (2026-2031)
    • 5.1.4 Global Flavored Veterinary Medication Sales Value by Region (%), (2020-2031)
  • 5.2 North America
    • 5.2.1 North America Flavored Veterinary Medication Sales Value, 2020-2031
    • 5.2.2 North America Flavored Veterinary Medication Sales Value by Country (%), 2024 VS 2031
  • 5.3 Europe
    • 5.3.1 Europe Flavored Veterinary Medication Sales Value, 2020-2031
    • 5.3.2 Europe Flavored Veterinary Medication Sales Value by Country (%), 2024 VS 2031
  • 5.4 Asia Pacific
    • 5.4.1 Asia Pacific Flavored Veterinary Medication Sales Value, 2020-2031
    • 5.4.2 Asia Pacific Flavored Veterinary Medication Sales Value by Region (%), 2024 VS 2031
  • 5.5 South America
    • 5.5.1 South America Flavored Veterinary Medication Sales Value, 2020-2031
    • 5.5.2 South America Flavored Veterinary Medication Sales Value by Country (%), 2024 VS 2031
  • 5.6 Middle East & Africa
    • 5.6.1 Middle East & Africa Flavored Veterinary Medication Sales Value, 2020-2031
    • 5.6.2 Middle East & Africa Flavored Veterinary Medication Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

  • 6.1 Key Countries/Regions Flavored Veterinary Medication Sales Value Growth Trends, 2020 VS 2024 VS 2031
  • 6.2 Key Countries/Regions Flavored Veterinary Medication Sales Value, 2020-2031
  • 6.3 United States
    • 6.3.1 United States Flavored Veterinary Medication Sales Value, 2020-2031
    • 6.3.2 United States Flavored Veterinary Medication Sales Value by Type (%), 2024 VS 2031
    • 6.3.3 United States Flavored Veterinary Medication Sales Value by Application, 2024 VS 2031
  • 6.4 Europe
    • 6.4.1 Europe Flavored Veterinary Medication Sales Value, 2020-2031
    • 6.4.2 Europe Flavored Veterinary Medication Sales Value by Type (%), 2024 VS 2031
    • 6.4.3 Europe Flavored Veterinary Medication Sales Value by Application, 2024 VS 2031
  • 6.5 China
    • 6.5.1 China Flavored Veterinary Medication Sales Value, 2020-2031
    • 6.5.2 China Flavored Veterinary Medication Sales Value by Type (%), 2024 VS 2031
    • 6.5.3 China Flavored Veterinary Medication Sales Value by Application, 2024 VS 2031
  • 6.6 Japan
    • 6.6.1 Japan Flavored Veterinary Medication Sales Value, 2020-2031
    • 6.6.2 Japan Flavored Veterinary Medication Sales Value by Type (%), 2024 VS 2031
    • 6.6.3 Japan Flavored Veterinary Medication Sales Value by Application, 2024 VS 2031
  • 6.7 South Korea
    • 6.7.1 South Korea Flavored Veterinary Medication Sales Value, 2020-2031
    • 6.7.2 South Korea Flavored Veterinary Medication Sales Value by Type (%), 2024 VS 2031
    • 6.7.3 South Korea Flavored Veterinary Medication Sales Value by Application, 2024 VS 2031
  • 6.8 Southeast Asia
    • 6.8.1 Southeast Asia Flavored Veterinary Medication Sales Value, 2020-2031
    • 6.8.2 Southeast Asia Flavored Veterinary Medication Sales Value by Type (%), 2024 VS 2031
    • 6.8.3 Southeast Asia Flavored Veterinary Medication Sales Value by Application, 2024 VS 2031
  • 6.9 India
    • 6.9.1 India Flavored Veterinary Medication Sales Value, 2020-2031
    • 6.9.2 India Flavored Veterinary Medication Sales Value by Type (%), 2024 VS 2031
    • 6.9.3 India Flavored Veterinary Medication Sales Value by Application, 2024 VS 2031

7 Company Profiles

  • 7.1 Boehringer Ingelheim
    • 7.1.1 Boehringer Ingelheim Profile
    • 7.1.2 Boehringer Ingelheim Main Business
    • 7.1.3 Boehringer Ingelheim Flavored Veterinary Medication Products, Services and Solutions
    • 7.1.4 Boehringer Ingelheim Flavored Veterinary Medication Revenue (US$ Million) & (2020-2025)
    • 7.1.5 Boehringer Ingelheim Recent Developments
  • 7.2 Elanco Animal Health
    • 7.2.1 Elanco Animal Health Profile
    • 7.2.2 Elanco Animal Health Main Business
    • 7.2.3 Elanco Animal Health Flavored Veterinary Medication Products, Services and Solutions
    • 7.2.4 Elanco Animal Health Flavored Veterinary Medication Revenue (US$ Million) & (2020-2025)
    • 7.2.5 Elanco Animal Health Recent Developments
  • 7.3 Zoetis
    • 7.3.1 Zoetis Profile
    • 7.3.2 Zoetis Main Business
    • 7.3.3 Zoetis Flavored Veterinary Medication Products, Services and Solutions
    • 7.3.4 Zoetis Flavored Veterinary Medication Revenue (US$ Million) & (2020-2025)
    • 7.3.5 Zoetis Recent Developments
  • 7.4 Merck & Co.
    • 7.4.1 Merck & Co. Profile
    • 7.4.2 Merck & Co. Main Business
    • 7.4.3 Merck & Co. Flavored Veterinary Medication Products, Services and Solutions
    • 7.4.4 Merck & Co. Flavored Veterinary Medication Revenue (US$ Million) & (2020-2025)
    • 7.4.5 Merck & Co. Recent Developments
  • 7.5 Ceva
    • 7.5.1 Ceva Profile
    • 7.5.2 Ceva Main Business
    • 7.5.3 Ceva Flavored Veterinary Medication Products, Services and Solutions
    • 7.5.4 Ceva Flavored Veterinary Medication Revenue (US$ Million) & (2020-2025)
    • 7.5.5 Ceva Recent Developments
  • 7.6 Vetoquinol
    • 7.6.1 Vetoquinol Profile
    • 7.6.2 Vetoquinol Main Business
    • 7.6.3 Vetoquinol Flavored Veterinary Medication Products, Services and Solutions
    • 7.6.4 Vetoquinol Flavored Veterinary Medication Revenue (US$ Million) & (2020-2025)
    • 7.6.5 Vetoquinol Recent Developments
  • 7.7 Wedgewood Pharmacy
    • 7.7.1 Wedgewood Pharmacy Profile
    • 7.7.2 Wedgewood Pharmacy Main Business
    • 7.7.3 Wedgewood Pharmacy Flavored Veterinary Medication Products, Services and Solutions
    • 7.7.4 Wedgewood Pharmacy Flavored Veterinary Medication Revenue (US$ Million) & (2020-2025)
    • 7.7.5 Wedgewood Pharmacy Recent Developments
  • 7.8 Virbac
    • 7.8.1 Virbac Profile
    • 7.8.2 Virbac Main Business
    • 7.8.3 Virbac Flavored Veterinary Medication Products, Services and Solutions
    • 7.8.4 Virbac Flavored Veterinary Medication Revenue (US$ Million) & (2020-2025)
    • 7.8.5 Virbac Recent Developments
  • 7.9 BOVA
    • 7.9.1 BOVA Profile
    • 7.9.2 BOVA Main Business
    • 7.9.3 BOVA Flavored Veterinary Medication Products, Services and Solutions
    • 7.9.4 BOVA Flavored Veterinary Medication Revenue (US$ Million) & (2020-2025)
    • 7.9.5 BOVA Recent Developments
  • 7.10 Lee Silsby Compounding Pharmacy
    • 7.10.1 Lee Silsby Compounding Pharmacy Profile
    • 7.10.2 Lee Silsby Compounding Pharmacy Main Business
    • 7.10.3 Lee Silsby Compounding Pharmacy Flavored Veterinary Medication Products, Services and Solutions
    • 7.10.4 Lee Silsby Compounding Pharmacy Flavored Veterinary Medication Revenue (US$ Million) & (2020-2025)
    • 7.10.5 Lee Silsby Compounding Pharmacy Recent Developments
  • 7.11 Golden Gate
    • 7.11.1 Golden Gate Profile
    • 7.11.2 Golden Gate Main Business
    • 7.11.3 Golden Gate Flavored Veterinary Medication Products, Services and Solutions
    • 7.11.4 Golden Gate Flavored Veterinary Medication Revenue (US$ Million) & (2020-2025)
    • 7.11.5 Golden Gate Recent Developments
  • 7.12 China Animal Healthcare
    • 7.12.1 China Animal Healthcare Profile
    • 7.12.2 China Animal Healthcare Main Business
    • 7.12.3 China Animal Healthcare Flavored Veterinary Medication Products, Services and Solutions
    • 7.12.4 China Animal Healthcare Flavored Veterinary Medication Revenue (US$ Million) & (2020-2025)
    • 7.12.5 China Animal Healthcare Recent Developments
  • 7.13 Qingdao Yibang
    • 7.13.1 Qingdao Yibang Profile
    • 7.13.2 Qingdao Yibang Main Business
    • 7.13.3 Qingdao Yibang Flavored Veterinary Medication Products, Services and Solutions
    • 7.13.4 Qingdao Yibang Flavored Veterinary Medication Revenue (US$ Million) & (2020-2025)
    • 7.13.5 Qingdao Yibang Recent Developments
  • 7.14 Rupu Bio
    • 7.14.1 Rupu Bio Profile
    • 7.14.2 Rupu Bio Main Business
    • 7.14.3 Rupu Bio Flavored Veterinary Medication Products, Services and Solutions
    • 7.14.4 Rupu Bio Flavored Veterinary Medication Revenue (US$ Million) & (2020-2025)
    • 7.14.5 Rupu Bio Recent Developments

8 Industry Chain Analysis

  • 8.1 Flavored Veterinary Medication Industrial Chain
  • 8.2 Flavored Veterinary Medication Upstream Analysis
    • 8.2.1 Key Raw Materials
    • 8.2.2 Raw Materials Key Suppliers
    • 8.2.3 Manufacturing Cost Structure
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis (Customers Analysis)
  • 8.5 Sales Model and Sales Channels
    • 8.5.1 Flavored Veterinary Medication Sales Model
    • 8.5.2 Sales Channel
    • 8.5.3 Flavored Veterinary Medication Distributors

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
      • 10.1.1.1 Research Programs/Design
      • 10.1.1.2 Market Size Estimation
      • 10.1.1.3 Market Breakdown and Data Triangulation
    • 10.1.2 Data Source
      • 10.1.2.1 Secondary Sources
      • 10.1.2.2 Primary Sources
  • 10.2 Author Details
  • 10.3 Disclaimer

List of Tables

  • Table 1. Flavored Veterinary Medication Market Trends
  • Table 2. Flavored Veterinary Medication Market Drivers & Opportunity
  • Table 3. Flavored Veterinary Medication Market Challenges
  • Table 4. Flavored Veterinary Medication Market Restraints
  • Table 5. Global Flavored Veterinary Medication Revenue by Company (2020-2025) & (US$ Million)
  • Table 6. Global Flavored Veterinary Medication Revenue Market Share by Company (2020-2025)
  • Table 7. Key Companies Flavored Veterinary Medication Manufacturing Base Distribution and Headquarters
  • Table 8. Key Companies Flavored Veterinary Medication Product Type
  • Table 9. Key Companies Time to Begin Mass Production of Flavored Veterinary Medication
  • Table 10. Global Flavored Veterinary Medication Companies Market Concentration Ratio (CR5 and HHI)
  • Table 11. Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Flavored Veterinary Medication as of 2024)
  • Table 12. Mergers & Acquisitions, Expansion Plans
  • Table 13. Global Flavored Veterinary Medication Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 14. Global Flavored Veterinary Medication Sales Value by Type (2020-2025) & (US$ Million)
  • Table 15. Global Flavored Veterinary Medication Sales Value by Type (2026-2031) & (US$ Million)
  • Table 16. Global Flavored Veterinary Medication Sales Market Share in Value by Type (2020-2025)
  • Table 17. Global Flavored Veterinary Medication Sales Market Share in Value by Type (2026-2031)
  • Table 18. Global Flavored Veterinary Medication Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 19. Global Flavored Veterinary Medication Sales Value by Application (2020-2025) & (US$ Million)
  • Table 20. Global Flavored Veterinary Medication Sales Value by Application (2026-2031) & (US$ Million)
  • Table 21. Global Flavored Veterinary Medication Sales Market Share in Value by Application (2020-2025)
  • Table 22. Global Flavored Veterinary Medication Sales Market Share in Value by Application (2026-2031)
  • Table 23. Global Flavored Veterinary Medication Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
  • Table 24. Global Flavored Veterinary Medication Sales Value by Region (2020-2025) & (US$ Million)
  • Table 25. Global Flavored Veterinary Medication Sales Value by Region (2026-2031) & (US$ Million)
  • Table 26. Global Flavored Veterinary Medication Sales Value by Region (2020-2025) & (%)
  • Table 27. Global Flavored Veterinary Medication Sales Value by Region (2026-2031) & (%)
  • Table 28. Key Countries/Regions Flavored Veterinary Medication Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
  • Table 29. Key Countries/Regions Flavored Veterinary Medication Sales Value, (2020-2025) & (US$ Million)
  • Table 30. Key Countries/Regions Flavored Veterinary Medication Sales Value, (2026-2031) & (US$ Million)
  • Table 31. Boehringer Ingelheim Basic Information List
  • Table 32. Boehringer Ingelheim Description and Business Overview
  • Table 33. Boehringer Ingelheim Flavored Veterinary Medication Products, Services and Solutions
  • Table 34. Revenue (US$ Million) in Flavored Veterinary Medication Business of Boehringer Ingelheim (2020-2025)
  • Table 35. Boehringer Ingelheim Recent Developments
  • Table 36. Elanco Animal Health Basic Information List
  • Table 37. Elanco Animal Health Description and Business Overview
  • Table 38. Elanco Animal Health Flavored Veterinary Medication Products, Services and Solutions
  • Table 39. Revenue (US$ Million) in Flavored Veterinary Medication Business of Elanco Animal Health (2020-2025)
  • Table 40. Elanco Animal Health Recent Developments
  • Table 41. Zoetis Basic Information List
  • Table 42. Zoetis Description and Business Overview
  • Table 43. Zoetis Flavored Veterinary Medication Products, Services and Solutions
  • Table 44. Revenue (US$ Million) in Flavored Veterinary Medication Business of Zoetis (2020-2025)
  • Table 45. Zoetis Recent Developments
  • Table 46. Merck & Co. Basic Information List
  • Table 47. Merck & Co. Description and Business Overview
  • Table 48. Merck & Co. Flavored Veterinary Medication Products, Services and Solutions
  • Table 49. Revenue (US$ Million) in Flavored Veterinary Medication Business of Merck & Co. (2020-2025)
  • Table 50. Merck & Co. Recent Developments
  • Table 51. Ceva Basic Information List
  • Table 52. Ceva Description and Business Overview
  • Table 53. Ceva Flavored Veterinary Medication Products, Services and Solutions
  • Table 54. Revenue (US$ Million) in Flavored Veterinary Medication Business of Ceva (2020-2025)
  • Table 55. Ceva Recent Developments
  • Table 56. Vetoquinol Basic Information List
  • Table 57. Vetoquinol Description and Business Overview
  • Table 58. Vetoquinol Flavored Veterinary Medication Products, Services and Solutions
  • Table 59. Revenue (US$ Million) in Flavored Veterinary Medication Business of Vetoquinol (2020-2025)
  • Table 60. Vetoquinol Recent Developments
  • Table 61. Wedgewood Pharmacy Basic Information List
  • Table 62. Wedgewood Pharmacy Description and Business Overview
  • Table 63. Wedgewood Pharmacy Flavored Veterinary Medication Products, Services and Solutions
  • Table 64. Revenue (US$ Million) in Flavored Veterinary Medication Business of Wedgewood Pharmacy (2020-2025)
  • Table 65. Wedgewood Pharmacy Recent Developments
  • Table 66. Virbac Basic Information List
  • Table 67. Virbac Description and Business Overview
  • Table 68. Virbac Flavored Veterinary Medication Products, Services and Solutions
  • Table 69. Revenue (US$ Million) in Flavored Veterinary Medication Business of Virbac (2020-2025)
  • Table 70. Virbac Recent Developments
  • Table 71. BOVA Basic Information List
  • Table 72. BOVA Description and Business Overview
  • Table 73. BOVA Flavored Veterinary Medication Products, Services and Solutions
  • Table 74. Revenue (US$ Million) in Flavored Veterinary Medication Business of BOVA (2020-2025)
  • Table 75. BOVA Recent Developments
  • Table 76. Lee Silsby Compounding Pharmacy Basic Information List
  • Table 77. Lee Silsby Compounding Pharmacy Description and Business Overview
  • Table 78. Lee Silsby Compounding Pharmacy Flavored Veterinary Medication Products, Services and Solutions
  • Table 79. Revenue (US$ Million) in Flavored Veterinary Medication Business of Lee Silsby Compounding Pharmacy (2020-2025)
  • Table 80. Lee Silsby Compounding Pharmacy Recent Developments
  • Table 81. Golden Gate Basic Information List
  • Table 82. Golden Gate Description and Business Overview
  • Table 83. Golden Gate Flavored Veterinary Medication Products, Services and Solutions
  • Table 84. Revenue (US$ Million) in Flavored Veterinary Medication Business of Golden Gate (2020-2025)
  • Table 85. Golden Gate Recent Developments
  • Table 86. China Animal Healthcare Basic Information List
  • Table 87. China Animal Healthcare Description and Business Overview
  • Table 88. China Animal Healthcare Flavored Veterinary Medication Products, Services and Solutions
  • Table 89. Revenue (US$ Million) in Flavored Veterinary Medication Business of China Animal Healthcare (2020-2025)
  • Table 90. China Animal Healthcare Recent Developments
  • Table 91. Qingdao Yibang Basic Information List
  • Table 92. Qingdao Yibang Description and Business Overview
  • Table 93. Qingdao Yibang Flavored Veterinary Medication Products, Services and Solutions
  • Table 94. Revenue (US$ Million) in Flavored Veterinary Medication Business of Qingdao Yibang (2020-2025)
  • Table 95. Qingdao Yibang Recent Developments
  • Table 96. Rupu Bio Basic Information List
  • Table 97. Rupu Bio Description and Business Overview
  • Table 98. Rupu Bio Flavored Veterinary Medication Products, Services and Solutions
  • Table 99. Revenue (US$ Million) in Flavored Veterinary Medication Business of Rupu Bio (2020-2025)
  • Table 100. Rupu Bio Recent Developments
  • Table 101. Key Raw Materials Lists
  • Table 102. Raw Materials Key Suppliers Lists
  • Table 103. Flavored Veterinary Medication Downstream Customers
  • Table 104. Flavored Veterinary Medication Distributors List
  • Table 105. Research Programs/Design for This Report
  • Table 106. Key Data Information from Secondary Sources
  • Table 107. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Flavored Veterinary Medication Product Picture
  • Figure 2. Global Flavored Veterinary Medication Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
  • Figure 3. Global Flavored Veterinary Medication Sales Value (2020-2031) & (US$ Million)
  • Figure 4. Flavored Veterinary Medication Report Years Considered
  • Figure 5. Global Flavored Veterinary Medication Players Revenue Ranking (2024) & (US$ Million)
  • Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Flavored Veterinary Medication Revenue in 2024
  • Figure 7. Flavored Veterinary Medication Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
  • Figure 8. Meat Flavored Picture
  • Figure 9. Fish Flavored Picture
  • Figure 10. Fruit Flavored Picture
  • Figure 11. Others Picture
  • Figure 12. Global Flavored Veterinary Medication Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 13. Global Flavored Veterinary Medication Sales Value Market Share by Type, 2024 & 2031
  • Figure 14. Product Picture of Dogs
  • Figure 15. Product Picture of Cats
  • Figure 16. Product Picture of Other
  • Figure 17. Global Flavored Veterinary Medication Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 18. Global Flavored Veterinary Medication Sales Value Market Share by Application, 2024 & 2031
  • Figure 19. North America Flavored Veterinary Medication Sales Value (2020-2031) & (US$ Million)
  • Figure 20. North America Flavored Veterinary Medication Sales Value by Country (%), 2024 VS 2031
  • Figure 21. Europe Flavored Veterinary Medication Sales Value, (2020-2031) & (US$ Million)
  • Figure 22. Europe Flavored Veterinary Medication Sales Value by Country (%), 2024 VS 2031
  • Figure 23. Asia Pacific Flavored Veterinary Medication Sales Value, (2020-2031) & (US$ Million)
  • Figure 24. Asia Pacific Flavored Veterinary Medication Sales Value by Region (%), 2024 VS 2031
  • Figure 25. South America Flavored Veterinary Medication Sales Value, (2020-2031) & (US$ Million)
  • Figure 26. South America Flavored Veterinary Medication Sales Value by Country (%), 2024 VS 2031
  • Figure 27. Middle East & Africa Flavored Veterinary Medication Sales Value, (2020-2031) & (US$ Million)
  • Figure 28. Middle East & Africa Flavored Veterinary Medication Sales Value by Country (%), 2024 VS 2031
  • Figure 29. Key Countries/Regions Flavored Veterinary Medication Sales Value (%), (2020-2031)
  • Figure 30. United States Flavored Veterinary Medication Sales Value, (2020-2031) & (US$ Million)
  • Figure 31. United States Flavored Veterinary Medication Sales Value by Type (%), 2024 VS 2031
  • Figure 32. United States Flavored Veterinary Medication Sales Value by Application (%), 2024 VS 2031
  • Figure 33. Europe Flavored Veterinary Medication Sales Value, (2020-2031) & (US$ Million)
  • Figure 34. Europe Flavored Veterinary Medication Sales Value by Type (%), 2024 VS 2031
  • Figure 35. Europe Flavored Veterinary Medication Sales Value by Application (%), 2024 VS 2031
  • Figure 36. China Flavored Veterinary Medication Sales Value, (2020-2031) & (US$ Million)
  • Figure 37. China Flavored Veterinary Medication Sales Value by Type (%), 2024 VS 2031
  • Figure 38. China Flavored Veterinary Medication Sales Value by Application (%), 2024 VS 2031
  • Figure 39. Japan Flavored Veterinary Medication Sales Value, (2020-2031) & (US$ Million)
  • Figure 40. Japan Flavored Veterinary Medication Sales Value by Type (%), 2024 VS 2031
  • Figure 41. Japan Flavored Veterinary Medication Sales Value by Application (%), 2024 VS 2031
  • Figure 42. South Korea Flavored Veterinary Medication Sales Value, (2020-2031) & (US$ Million)
  • Figure 43. South Korea Flavored Veterinary Medication Sales Value by Type (%), 2024 VS 2031
  • Figure 44. South Korea Flavored Veterinary Medication Sales Value by Application (%), 2024 VS 2031
  • Figure 45. Southeast Asia Flavored Veterinary Medication Sales Value, (2020-2031) & (US$ Million)
  • Figure 46. Southeast Asia Flavored Veterinary Medication Sales Value by Type (%), 2024 VS 2031
  • Figure 47. Southeast Asia Flavored Veterinary Medication Sales Value by Application (%), 2024 VS 2031
  • Figure 48. India Flavored Veterinary Medication Sales Value, (2020-2031) & (US$ Million)
  • Figure 49. India Flavored Veterinary Medication Sales Value by Type (%), 2024 VS 2031
  • Figure 50. India Flavored Veterinary Medication Sales Value by Application (%), 2024 VS 2031
  • Figure 51. Flavored Veterinary Medication Industrial Chain
  • Figure 52. Flavored Veterinary Medication Manufacturing Cost Structure
  • Figure 53. Channels of Distribution (Direct Sales, and Distribution)
  • Figure 54. Bottom-up and Top-down Approaches for This Report
  • Figure 55. Data Triangulation
  • Figure 56. Key Executives Interviewed